World Of Taxonomy
65862-105Level 3

Efavirenz (Efavirenz)

**Product type:** Human Prescription Drug

**Active ingredient:** EFAVIRENZ

**Strength:** 100 mg/1

**Dosage form:** Capsule

**Route:** Oral

**Labeler:** Aurobindo Pharma Limited

**Marketing category:** ANDA (ANDA078064)

**Pharmacologic class:** Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]

GET/api/v1/systems/ndc_fda/nodes/65862-105
Official DownloadPublic Domain (US Government)Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.